James L. Langford

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Taruna Ikrar, R. Dillman, G. Nistor, 2022, Human vaccines & immunotherapeutics.

Prevention of Symptomatic Covid-19 Infection by Personal Dendritic Cell Vaccine

R. Dillman, H. Keirstead, G. Nistor, 2023, Journal of Vaccines, Immunology and Immunopathology.